| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 34.5× | −1.7× | |
| Price / Book | −20.5× | 2.0× | |
| Price / Sales | 0.2× | 4.0× | |
| Price / Free cash flow | 13.1× | −1.6× | |
| EV / EBITDA | 18.0× | −1.2× | |
| Earnings yield | 2.9% | −14.6% | |
| Free cash flow yield | 7.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,252.49 | −0.36% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $255.30 | −0.10% | $615.25B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $286.70 | +0.45% | $506.63B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $401.19 | −0.06% | $360.11B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.14 | +0.82% | $363.02B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.90 | +0.19% | $279.15B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $166.09 | +0.41% | $257.59B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $691.88 | +0.27% | $255.82B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $431.23 | −0.29% | $233.14B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.58 | +0.25% | $194.15B | 22.8× | 37.5% | +32.0% |
